|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Amynta Agency Borrower, Inc. New York, May 20, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Amynta Agency Borrower, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
The rating outlook for Amynta is stable. Amynta's ratings reflect its growing market presence in US warranty products, particularly vehicle service contracts, which it sells through multiple distribution channels. Amynta also owns managing general agency operations that target small businesses and distribute a wide array of property and casualty products through regional insurance agents and service providers.
How do we determine whether Amtrust Financial Services, Inc. (NASDAQ:AFSI) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data […]
AmTrust Financial Services (AFSI) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Moody's Investors Service has affirmed the B3 corporate family rating and B3-PD probability of default rating of Amynta Agency Borrower, Inc. (Amynta, formerly Mayfield Agency Borrower, Inc.) following the company's announcement that it is repricing its first-lien term loan and increasing it by $50 million. Moody's has also affirmed the B2 ratings on Amynta's first-lien credit facilities and the Caa2 rating on its second-lien term loan (see list below).
Kai Liekefett, Leader of Shareholder Activism at Sidley Austin When Starboard Value shocked corporate America by winning all 12 board seats at Darden Restaurants in a 2014 proxy fight, other companies were spooked into conceding seats to avoid embarrassment. But since then, companies have been less likely to give up seats as big shareholders took […]
For billionaire investment titan Carl Icahn, the second quarter of the year was a busy one. According to a filing submitted to the SEC earlier this week, Icahn increased his stake in troubled nutrition company Herbalife Nutrition Ltd ( HLF) as well as his own namesake Icahn Enterprises LP ( IEP), per a report by Proactive Investors. While it's difficult to say whether or not any given position in the billionaire's portfolio could be the target of activist maneuvering, there are at least three major companies representing new positions in Icahn's portfolio during the second quarter of the year.
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and selling. Takeaways From ...
Shares of commercial insurer AmTrust (NASDAQ:AFSI) were scheduled to open Jul. 3 at $14.60 per share, despite having been approved for sale to private equity at $14.75 per share. AmTrust is a property and casualty insurance company specializing in small businesses and workers’ compensation. Shareholders including Carl Icahn approved a sweetened bid for the company last month.
Rating giant A.M. Best downgrades the ratings for AmTrust Financial (AFSI) with the outlook remaining stable. The ratings denote the company's sturdy balance sheet and its sustained operating efficiency.